𝔖 Bobbio Scriptorium
✦   LIBER   ✦

O-218 Single-agent Gemcitabine (G) and Docetaxel (D) given sequentially every 3 weeks in advanced NSCLC: Final results and quality of life assessment of a randomised phase II study show effective treatment

✍ Scribed by Mezger, Joerg; Pilz, Lothar R.; Koschel, Gisela; Schott, Katrin; Hruska, D.; Manegold, Christian

Book ID
118571608
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
170 KB
Volume
41
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

P-554 Randomized Phase II study of first
P-554 Randomized Phase II study of first-line docetaxel (D)/ gemcitabine (G) doublet chemotherapy versus fixed duration (3 cycles) sequential single agent chemotherapy (D then G) in Stage IIIB/IV non-small cell lung cancer (NSCLC)β€”Final Results. A study by the NSW and Australian Lung Cancer Trials Group
✍ Pavlakis, N.; McCowatt, S.; Lewis, C.; Marx, G.; Abell, F.; Della-Fiorentina, S. πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 144 KB